Related Experiment Video
Updated: Jul 10, 2025

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
Published on: April 5, 2024
Characterizing Adeno-Associated Virus Capsids with Both Denaturing and Intact Analysis Methods
Jack P Ryan1, Marius M Kostelic2, Chih-Chieh Hsieh2
1University of North Carolina, Department of Chemistry, Chapel Hill, North Carolina 27599, United States.
New mass spectrometry methods accurately characterize adeno-associated virus (AAV) capsids and viral proteins (VPs). This improves quality control for gene therapy applications by distinguishing empty and filled capsids and analyzing VP sequences.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Gene Therapy
Background:
- Adeno-associated viruses (AAVs) are crucial gene delivery vectors for treating human diseases.
- Diverse AAV serotypes target specific cells and tissues, necessitating precise composition analysis.
- Current analytical methods struggle with AAV subunit selectivity, intact capsid assessment, and empty/filled capsid differentiation.
Purpose of the Study:
- To develop and apply advanced analytical workflows for comprehensive AAV capsid characterization.
- To improve quality control for gene therapy by accurately assessing capsid composition and viral protein (VP) subunits.
- To differentiate between empty and filled AAV capsids and analyze VP sequences and modifications.
Main Methods:
- Utilized selective temporal overview of resonant ion (STORI)-based charge detection-mass spectrometry (CD-MS) for intact capsid analysis.
- Employed liquid chromatography, ion mobility spectrometry, and mass spectrometry (LC-IMS-MS) for denatured capsid subunit analysis.
- Applied this combined approach to AAV serotypes 2, 6, and 8.
Main Results:
- Successfully characterized intact empty and filled capsid ratios for AAV2, AAV6, and AAV8.
- Analyzed distinct viral protein (VP) sequences and post-translational modifications within the AAV capsids.
- Demonstrated the capability of the combined analytical workflows to overcome limitations of existing methods.
Conclusions:
- The integrated STORI-CD-MS and LC-IMS-MS approach provides enhanced selectivity and accuracy for AAV characterization.
- This methodology is vital for ensuring the quality and efficacy of AAV-based gene therapies.
- Accurate analysis of AAV capsid composition is critical for precise gene delivery and therapeutic outcomes.
More Related Videos
12:57Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
Published on: November 16, 2017
14:49A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins
Published on: June 12, 2018